Successful Treatment of a Patient with a Thymoma and Pure Red-Cell Aplasia with Octreotide and Prednisone

Authors:
  • ACAnnamaria Colao
    Annamaria Colao
  • EVEmilia Vergara
    Emilia Vergara
  • PVPaola Varrella
    Paola Varrella
  • EBEdoardo Biondi
    Edoardo Biondi
  • CSCarmine Selleri
    Carmine Selleri
  • LCLucio Catalano
    Lucio Catalano
  • GLGaetano Lombardi
    Gaetano Lombardi
  • ABAngelo Raffaele Bianco
    Angelo Raffaele Bianco
  • MSMarco Salvatore
    Marco Salvatore
Publisher website
Google Scholar
Abstract
Thymomas are rare epithelial neoplasms frequently associated with myasthenia gravis, hypogammaglobulinemia, and pure red-cell aplasia.1-11 In pure red-cell aplasia, autoantibodies against early and late erythroid-cell progenitors or erythropoietin, as well as inhibitory cellular immune mechanisms, have been implicated.9-11 Limited information suggests that patients with pure red-cell aplasia and thymoma have a poor prognosis.6,7,10

This publication has 21 references indexed in Scilit: